243 related articles for article (PubMed ID: 31982622)
21. Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study.
Tadec L; Talarmin JP; Gastinne T; Bretonnière C; Miegeville M; Le Pape P; Morio F
Mycoses; 2016 May; 59(5):296-303. PubMed ID: 26806101
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of Fluconazole versus Echinocandins for Treatment of Candidemia Caused by Susceptible Common
Kim JH; Suh JW; Kim MJ
J Fungi (Basel); 2023 May; 9(5):. PubMed ID: 37233250
[TBL] [Abstract][Full Text] [Related]
23. Impact of empirical treatment with antifungal agents on survival of patients with candidemia.
Poves-Alvarez R; Cano-Hernández B; Muñoz-Moreno MF; Balbás-Alvarez S; Román-García P; Gómez-Sánchez E; Martínez-Rafael B; Gómez-Pesquera E; Lorenzo-López M; Alvarez-Fuente E; de la Varga O; Flores M; Eiros JM; Tamayo E; Heredia-Rodríguez M
Rev Esp Quimioter; 2019 Feb; 32(1):6-14. PubMed ID: 30499639
[TBL] [Abstract][Full Text] [Related]
24. Impact of therapeutic strategies on the prognosis of candidemia in the ICU.
Puig-Asensio M; Pemán J; Zaragoza R; Garnacho-Montero J; Martín-Mazuelos E; Cuenca-Estrella M; Almirante B; ; ; ;
Crit Care Med; 2014 Jun; 42(6):1423-32. PubMed ID: 24557426
[TBL] [Abstract][Full Text] [Related]
25. Treatment of candidemia with echinocandins: data on hospital resource use from a real world setting.
Wade RL; Chaudhari P; Campbell RS; Hays HD; Nathanson BH; Yi J; Horn D
J Med Econ; 2012; 15(6):1130-8. PubMed ID: 22788668
[TBL] [Abstract][Full Text] [Related]
26. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).
Pfaller MA; Messer SA; Moet GJ; Jones RN; Castanheira M
Int J Antimicrob Agents; 2011 Jul; 38(1):65-9. PubMed ID: 21514797
[TBL] [Abstract][Full Text] [Related]
27. Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia.
Gebretekle GB; Fentie AM; Gebremariam GT; Ali EE; Erku DA; Alemayehu T; Abebe W; Sander B
BMC Health Serv Res; 2022 Oct; 22(1):1302. PubMed ID: 36309674
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of antifungal therapy in patients with candidaemia based on susceptibility testing results: implications for antimicrobial stewardship programmes.
Shah DN; Yau R; Weston J; Lasco TM; Salazar M; Palmer HR; Garey KW
J Antimicrob Chemother; 2011 Sep; 66(9):2146-51. PubMed ID: 21700622
[TBL] [Abstract][Full Text] [Related]
29. Treatment Practices for Adults With Candidemia at 9 Active Surveillance Sites-United States, 2017-2018.
Gold JAW; Seagle EE; Nadle J; Barter DM; Czaja CA; Johnston H; Farley MM; Thomas S; Harrison LH; Fischer J; Pattee B; Mody RK; Phipps EC; Davis SS; Tesini BL; Zhang AY; Markus TM; Schaffner W; Lockhart SR; Vallabhaneni S; Jackson BR; Lyman M
Clin Infect Dis; 2021 Nov; 73(9):1609-1616. PubMed ID: 34079987
[TBL] [Abstract][Full Text] [Related]
30. Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010).
Lortholary O; Renaudat C; Sitbon K; Madec Y; Denoeud-Ndam L; Wolff M; Fontanet A; Bretagne S; Dromer F;
Intensive Care Med; 2014 Sep; 40(9):1303-12. PubMed ID: 25097069
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of candidemia and antifungal consumption in a large tertiary care Italian hospital over a 12-year period.
Mencarini J; Mantengoli E; Tofani L; Riccobono E; Fornaini R; Bartalesi F; Corti G; Farese A; Pecile P; Boni L; Rossolini GM; Bartoloni A
Infection; 2018 Aug; 46(4):469-476. PubMed ID: 29654496
[TBL] [Abstract][Full Text] [Related]
32. The epidemiology, antifungal use and risk factors of death in elderly patients with candidemia: a multicentre retrospective study.
Wang H; Liu N; Yin M; Han H; Yue J; Zhang F; Shan T; Guo H; Wu D
BMC Infect Dis; 2014 Nov; 14():609. PubMed ID: 25420435
[TBL] [Abstract][Full Text] [Related]
33. Antifungal susceptibility testing of a 10-year collection of Candida spp. isolated from patients with candidemia.
Iatta R; Caggiano G; Cuna T; Montagna MT
J Chemother; 2011 Apr; 23(2):92-6. PubMed ID: 21571625
[TBL] [Abstract][Full Text] [Related]
34. Hemodynamic changes in surgical intensive care unit patients undergoing echinocandin treatment.
Koch C; Schneck E; Arens C; Markmann M; Sander M; Henrich M; Weigand MA; Lichtenstern C
Int J Clin Pharm; 2020 Feb; 42(1):72-79. PubMed ID: 31748967
[TBL] [Abstract][Full Text] [Related]
35. Candidemia in Adult Patients in the ICU: A Reappraisal of Susceptibility Testing and Antifungal Therapy.
Chastain DB; White BP; Tu PJ; Chan S; Jackson BT; Kubbs KA; Bandali A; McDougal S; Henao-Martínez AF; Cluck DB
Ann Pharmacother; 2024 Mar; 58(3):305-321. PubMed ID: 37272474
[TBL] [Abstract][Full Text] [Related]
36. The Effect on mortality of fluconazole or echinocandins treatment in candidemia in internal medicine wards [corrected].
De Rosa FG; Corcione S; Filippini C; Raviolo S; Fossati L; Montrucchio C; Aldieri C; Petrolo A; Cavallo R; Di Perri G
PLoS One; 2015; 10(5):e0125149. PubMed ID: 25938486
[TBL] [Abstract][Full Text] [Related]
37. A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.
Rodriguez L; Bustamante B; Huaroto L; Agurto C; Illescas R; Ramirez R; Diaz A; Hidalgo J
PLoS One; 2017; 12(4):e0175172. PubMed ID: 28419092
[TBL] [Abstract][Full Text] [Related]
38. Mortality and risk factor analysis for Candida blood stream infection: A multicenter study.
Kato H; Yoshimura Y; Suido Y; Shimizu H; Ide K; Sugiyama Y; Matsuno K; Nakajima H
J Infect Chemother; 2019 May; 25(5):341-345. PubMed ID: 30718191
[TBL] [Abstract][Full Text] [Related]
39. Caspofungin: a review of its characteristics, activity, and use in intensive care units.
Hashemian SM; Farhadi T; Velayati AA
Expert Rev Anti Infect Ther; 2020 Dec; 18(12):1213-1220. PubMed ID: 32662712
[TBL] [Abstract][Full Text] [Related]
40. Antimicrobial susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections in a tertiary teaching hospital in Northern Taiwan.
Lin CC; Liu CP; Hsieh FC; Lee CM; Wang WS
J Microbiol Immunol Infect; 2015 Oct; 48(5):552-8. PubMed ID: 25315213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
